Heavy Menstrual Bleeding (HMB) clinical trials at University of California Health

1 research study open to eligible people

HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
open to eligible females ages 16-45
The purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacodynamics (PD) of multiple doses of ALN-6400 in adult and adolescent patients with VWD and HMB
at UCSF

Last updated: September 16, 2026